Eric Venker News Today

Roivant Sciences (NASDAQ:ROIV – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a report issued on Monday, Benzinga reports. They presently have a $18.00 target price on the stock. HC Wainwright’s price target indicates a potential upside of 64.53% from the company’s previous close. Other research analysts […]

Roivant Sciences (NASDAQ:ROIV – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $14.00 to $15.00 in a report released on Wednesday, Benzinga reports. They currently have a buy rating on the stock. ROIV has been the subject of several other reports. Piper Sandler started coverage on Roivant Sciences in a research […]

Roivant Sciences (NASDAQ:ROIV – Free Report) had its price target upped by HC Wainwright from $17.00 to $18.00 in a research note released on Wednesday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Roivant Sciences’ Q1 2025 earnings at ($0.25) EPS, Q2 2025 earnings […]

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed at $10.08, but opened at $10.72. Roivant Sciences shares last traded at $10.75, with a volume of 4,818,374 shares changing hands. Analysts Set New Price Targets A number of equities research analysts have recently […]

Truist Financial reiterated their buy rating on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research report released on Monday, Benzinga reports. Truist Financial currently has a $23.00 price objective on the stock. A number of other research analysts have also recently issued reports on ROIV. TheStreet raised shares of Roivant Sciences from […]

Deerfield Management Company L.P. Series C raised its position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 18.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,604,487 shares of the company’s stock after acquiring an additional 249,513 shares during […]

Wolfe Research started coverage on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research note published on Thursday, Marketbeat reports. The brokerage issued an outperform rating and a $17.00 price target on the stock. A number of other equities analysts have also recently commented on ROIV. Deutsche Bank Aktiengesellschaft started coverage on shares […]

Silverarc Capital Management LLC purchased a new position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 100,000 shares of the company’s stock, valued at approximately $1,168,000. A number of other institutional investors have also recently […]

Roivant Sciences (NASDAQ:ROIV – Get Free Report) had its target price reduced by stock analysts at HC Wainwright from $18.00 to $17.00 in a research note issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s target price would suggest a potential upside of 54.26% from the company’s […]

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) was the recipient of some unusual options trading on Tuesday. Investors acquired 8,333 call options on the company. This represents an increase of 169% compared to the average volume of 3,098 call options. Wall Street Analysts Forecast Growth Several research firms recently issued reports on ROIV. JPMorgan […]